Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)

NCT07739914 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hannover Medical School

Collaborators